Running head: HORMONE THERAPY AND BREAST CANCER 1
Hormone Therapy and Breast Cancer
HORMONE THERAPY AND BREAST CANCER 2
This paper discusses the risks associated with menopausal hormone therapy and the increased risk of breast cancer. Breast cancer cannot be prevented, but certain risk factors can be decreased or eliminated. The pathophysiology of hormone therapy related to breast cancer is explored. Studies show estrogen only therapy does not significantly increase the breast cancer risk. Combination estrogen/progesterone therapy does greatly increase the incidence of breast cancer. These risks are fluid, based on the type of therapy as well as duration of therapy.
HORMONE THERAPY AND BREAST CANCER 3
Breast cancer affects thousands of women each year. Approximately 290,170 women will be diagnosed with carcinoma in situ or invasive breast cancer this year. Out of those diagnosed, approximately 39,510 women will die this year from breast cancer. It is the second leading cancer in women and the second leading cause of cancer death in women (American Cancer Society para 1).
There are many risk factors for breast cancer. Some are non-reversible, such as genetics, heredity, gender, age, parity, and ethnicity. Others, such as obesity, hormones, smoking, and sedentary life can be altered with lifestyle changes. It is up to each individual woman to decrease her risk factors, if possible.
Hormone therapy for menopausal women remains a controversial topic. Millions of women each year use menopausal hormone therapy to alleviate the symptoms of menopause. Symptoms can range from mild to severe and differ among women. Common symptoms are hot flashes, mood changes, depression, anxiety, and sleep disturbances. Not all women experience symptoms related to...